ARK Investment Management 13F, Q3 2024
Cathie Wood · quarter ending 30 September 2024 · filed 31 October 2024 · SEC CIK 1697748
Common stock only: shares the fund reported owning at the quarter end, valued as filed.
Largest positions, Q3 2024
The 25 largest of 187 positions. Weights are against the whole filed book. Changes are in shares held, against the Q2 2024 filing.
| Company | Ticker | Value | % of book | vs Q2 2024 |
|---|---|---|---|---|
| Tesla Inc | TSLA | $1.20B | 11.0% | -14% shares |
| Roku Inc | ROKU | $837.84M | 7.7% | -12% shares |
| Coinbase Global Inc | COIN | $577.48M | 5.3% | -9% shares |
| ROBLOX Corp | RBLX | $524.10M | 4.8% | -11% shares |
| Block Inc | XYZ | $444.77M | 4.1% | -20% shares |
| Robinhood Markets Inc | HOOD | $420.96M | 3.9% | -6% shares |
| Palantir Technologies Inc | PLTR | $409.86M | 3.8% | -15% shares |
| Shopify Inc | SHOP | $374.33M | 3.4% | -6% shares |
| CRISPR Therapeutics AG | $352.29M | 3.2% | -4% shares | |
| UiPath Inc | PATH | $268.16M | 2.5% | -30% shares |
| Intellia Therapeutics Inc | NTLA | $251.85M | 2.3% | +6% shares |
| 10X Genomics Inc | TXG | $242.74M | 2.2% | +15% shares |
| Twist Bioscience Corp | TWST | $242.08M | 2.2% | -13% shares |
| DraftKings Inc | DKNG | $236.17M | 2.2% | -3% shares |
| Meta Platforms Inc | META | $227.79M | 2.1% | -8% shares |
| Recursion Pharmaceuticals Inc | RXRX | $215.95M | 2.0% | +16% shares |
| Teradyne Inc | TER | $205.26M | 1.9% | -4% shares |
| ARK 21Shares Bitcoin ETF | ARKB | $199.49M | 1.8% | -8% shares |
| PagerDuty Inc | PD | $180.89M | 1.6% | -8% shares |
| Veracyte Inc | VCYT | $167.50M | 1.5% | -28% shares |
| Beam Therapeutics Inc | BEAM | $160.01M | 1.5% | -14% shares |
| Unity Software Inc | U | $150.78M | 1.4% | -41% shares |
| Pinterest Inc | PINS | $141.41M | 1.3% | unchanged |
| Trade Desk Inc/The | TTD | $138.77M | 1.3% | -30% shares |
| Tempus AI Inc | TEM | $134.60M | 1.2% | +355% shares |
What changed since Q2 2024
Against the Q2 2024 filing, ARK Investment Management opened 12 new positions, added to 32, trimmed 133, left 10 unchanged and exited 15. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.
New positions
- GTLB$13.44M
- AUR$12.43M
- OKLO$8.32M
- Markforged Holding Corp$5.65M
- MediWound Ltd$1.81M
- Valens Semiconductor Ltd$1.36M
- ARKK$1.03M
- ALAR$784.7K
and 4 more
Exited
- TDOCwas $73.17M
- Verve Therapeutics Incwas $14.33M
- Ginkgo Bioworks Holdings Incwas $7.97M
- Markforged Holding Corpwas $7.72M
- EETHwas $5.37M
- Oddity Tech Ltdwas $2.53M
- MYNARIC AGNAMENS AKTIEN O Nwas $2.04M
- Hilan Ltdwas $1.98M
and 7 more
Other quarters
Source: SEC Form 13F-HR, accession 0001104659-24-113006, filed by ARK Investment Management LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.